Latest Breaking News On - Sirtex pty ltd - Page 1 : comparemela.com

Sirtex Medical secures positive approval of SIR-Spheres Y-90 resin microspheres for HCC treatment in Brazil

Sirtex Medical secures positive approval of SIR-Spheres Y-90 resin microspheres for HCC treatment in Brazil
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Joaquim maurKevinr smithBrazilian health regulatory agencyBrazilian society of interventional radiologyList of health proceduresBrazilian national agency of supplementary healthSirtex pty ltdBrazilian national agencySupplementary healthHealth proceduresChief executive officerMotta leal filhoBrazilian societyInterventional radiologyEndovascular surgeryPre market approval

Sirtex Medical secures positive approval of SIR-Spheres® Y-90 resin microspheres for HCC treatment in Brazil

/PRNewswire/ Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced that the Brazilian National Agency of.

Joaquim maurKevinr smithBrazilian health regulatory agencyBrazilian society of interventional radiologyList of health proceduresBrazilian national agency of supplementary healthSirtex pty ltdBrazilian national agencySupplementary healthHealth proceduresChief executive officerMotta leal filhoBrazilian societyInterventional radiologyEndovascular surgeryPre market approval

Sirtex Medical secures positive approval of SIR-Spheres® Y-90 resin microspheres for HCC treatment in Brazil

Sirtex Medical secures positive approval of SIR-Spheres® Y-90 resin microspheres for HCC treatment in Brazil
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres® Y-90 resin microspheres in China from the National Medical Products Administration

/PRNewswire/ Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today with its shareholder, Grand.

Tang weikunKevinr smithBoard at grand pharmaceutical groupNational medical products administrationSirtex pty ltdGrand pharmaceutical group limitedChief executive officerSirtex chinaGlobal regulatoryQuality assuranceGrand pharmaceutical groupSpheres ptyHealth care amp hospitalsMedical pharmaceuticalsMedical equipment

Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres Y-90 resin microspheres in China from the National Medical Products Administration

SIR-Spheres Y-90 resin microspheres are the first therapeutic radiopharmaceutical approved by the NMPA in 2022 WOBURN, Mass., Feb. 9, 2022 /PRNewswire/ Sirtex Medical ("Sirtex"), a leading

Tang weikunKevinr smithBoard at grand pharmaceutical groupNational medical products administrationSirtex pty ltdGrand pharmaceutical group limitedChief executive officerSirtex chinaGlobal regulatoryQuality assuranceGrand pharmaceutical groupSpheres pty